Login to Your Account



All This and Gout, Too

Sanofi, Regeneron Cozying Up: More Antibody Cash Long Term

By Randy Osborne


Wednesday, November 11, 2009
Sanofi-Aventis' expansion of its already-juicy deal with Regeneron Pharmaceuticals Inc. adds five years to the arrangement and at least $800 million, and may put some observers in mind of the historic partnership between Genentech Inc. and Roche Holdings AG. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription